PACTR201705002168252已完成未知
Which Is First Argon Laser Therapy Or Intravitreal Bivacizumab In Branch Retinal Vein Occlusion With Macular Oedema.
Ophthalmology department0 个研究点目标入组 60 人开始时间: 2017年4月3日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 45 Year(s) 至 65 Year(s)（—）
- 性别
- All
入选标准
- •patients with macular edema secondary to branch retinal vein occlusion
排除标准
- •The patients who had coexisting retinal disease (like diabetic retinopathy and epiretinal membrane); media opacities that could decrease visual acuity, or macular ischemia, concurrent ocular in¿ammation or infection, intraocular surgery (including post vitrectomized eyes) within the previous 3 months, patients of incomplete follow up
研究者
相似试验
Unknown
4 期
ALPI vs Medical Therapy Effects on Optic Nerve Structure & FunctionGlaucomaNCT00485238National University Hospital, Singapore60
招募中
不适用
Argon Laser for Trematodal Anterior UveitisPACTR202008516974176Sohag university30
Unknown
不适用
Comparitive study of Argon Laser and Aspirin in treatment of central serous chorioretinopathyPACTR201706002163811sohag university60
招募中
不适用
Effect of intravenous laser on acute renal injuryacute renal impairment.acute renal impairmentIRCT20111121008146N30Shahid Beheshti University of Medical Sciences40
已完成
不适用
Response to SLT vs. ALT in Patients Under 60 Years of AgeGlaucomaNCT01087684Sunnybrook Health Sciences Centre42